Ex Vivo Expanded Mesenchymal Stromal Cell Minimal Quality Requirements for Clinical Application
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Mesenchymal stromal cells (MSCs), as advanced therapy products, must satisfy all the requirements for human use of medicinal products, aiming to maintain the quality and safety of the cells. The MSC manufacturing process for clinical use should comply with the principles of Good Manufacturing Practice (GMP). This ensures that cell preparations are produced and controlled, from the collection and manipulation of raw materials, through the processing of intermediate products, to the quality controls, storage, labeling and packaging, and release. The objective of this document is to provide the minimal quality requirements for the MSC production and its delivery for clinical use, so that the safety of the final cell therapy product will not be compromised. For this purpose, the document evaluates the most important steps of GMP-compliant MSC production: the isolation and expansion process; the validation phase of the process, including all quality controls for the characterization, functionality, potency, and safety of MSCs; and the quality control at the batch release to guarantee the safety of patient infusion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kern, S., Eichler, H., Stoeve, J., Klüter, H., & Bieback, K. (2006) · STEM CELLS · doi:10.1634/stemcells.2005-0342 · Cited by 3,370 · cited 1×
“…cells, if compared to BM-MSCs, have been found to be genetically and morphologically more stable in culture [21], to have a lower senescence ratio [22], a higher proliferative capacity [21], to be able to retain differentiation potential for a longer period in culture [21], to be a more efficient…”
Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., & Ringdén, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16104-7 · Cited by 2,734
Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue
Izadpanah, R., Trygg, C., Patel, B., Kriedt, C., Dufour, J., Gimble, J. M., & Bunnell, B. A. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20904 · Cited by 670 · cited 3×
“…to have a lower senescence ratio [22], a higher proliferative capacity [21], to be able to retain differentiation potential for a longer period in culture [21], to be a more efficient support to hematopoiesis (both in vitro and in vivo) [23], and to have minor immunophenotypical differences [24].”
Tarte, K., Gaillard, J., Lataillade, J.-J., Fouillard, L., Becker, M., Mossafa, H., Tchirkov, A., Rouard, H., Henry, C., Splingard, M., et al. (2010) · Blood · doi:10.1182/blood-2009-05-219907 · Cited by 430 · cited 2×
“…or without chromosomal alterations, became senescent, without evidence of transformation either in vitro or in vivo, assuming that karyotyping and fluorescence in situ hybridization (FISH) results are not informative and are thus not adequate controls for the release of MSCs for clinical use [31].”
Cited by
Challenges and Controversies in Human Mesenchymal Stem Cell Therapy
Lukomska, B., Stanaszek, L., Zuba-Surma, E., Legosz, P., Sarzynska, S., & Drela, K. (2019) · Stem Cells International · doi:10.1155/2019/9628536 · Cited by 550
Giovannelli, L., Bari, E., Jommi, C., Tartara, F., Armocida, D., Garbossa, D., Cofano, F., Torre, M. L., & Segale, L. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.06.013 · Cited by 102
Self-citationProduction and quality testing of multipotent mesenchymal stromal cell therapeutics for clinical use
Bieback, K., Kuçi, S., & Schäfer, R. (2019) · Transfusion · doi:10.1111/trf.15252 · Cited by 24
“Viability is commonly assessed by “dye-exclusion” tests, such as trypan blue or propidium iodide, and MSC viability should exceed 90%.(57) • Stability and recovery.”
MethodBecherucci, V., Curini, L., Ceccantini, R., Bisin, S., Gori, V., Gentile, F., De Rienzo, E., Piccini, L., Bindi, B., Pavan, P., et al. (2021) · Biologicals · doi:10.1016/j.biologicals.2021.07.006 · Cited by 6
Metadata
- Authors
- Torre, M. L., Lucarelli, E., Guidi, S., Ferrari, M., Alessandri, G., De Girolamo, L., Pessina, A., Ferrero, I., & (GISM), O. B. O. T. G. I. S. M.
- Venue
- Stem Cells and Development
- Publisher
- SAGE Publications
- Published
- 2015-03-15
- Volume
- 24
- Issue
- 6
- Pages
- 677-685
- ISSN
- 1525-8165 (ISSN-L)
- 1547-3287
- 1557-8534
- OpenAlex
- W2022202873
- Cited by
- 93
- References
- 4
- FWCI
- 3.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ex Vivo Expanded Mesenchymal Stromal Cell Minimal Quality Requirements for Clinical Application. https://app.cochat.ai/papers/10.1089/scd.2014.0299
- The paper
- Torre, M. L., Lucarelli, E., Guidi, S., Ferrari, M., Alessandri, G., De Girolamo, L., Pessina, A., Ferrero, I., & (GISM), O. B. O. T. G. I. S. M. (2015). Ex Vivo Expanded Mesenchymal Stromal Cell Minimal Quality Requirements for Clinical Application. Stem Cells and Development. https://doi.org/10.1089/scd.2014.0299
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.